Last reviewed · How we verify
Propofol-remifentanil sedation
At a glance
| Generic name | Propofol-remifentanil sedation |
|---|---|
| Sponsor | Erasme University Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Headache
- Hypotension
- Nausea
- Vomiting
- Tachycardia
- Bradycardia
- Chills
- Gastrooesophageal reflux disease
- Oropharyngeal pain
- Hyperhidrosis
- Respiratory distress
- Stridor
Key clinical trials
- Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery. (NA)
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- Propofol vs Remifentanil for Sedation in Gastroscopy (NA)
- General Anesthesia vs Conscious Sedation for Radial Endobronchial Ultrasound (NA)
- Tubeless Strategy in Lung Transplantation: A Prospective Single-Arm Study (NA)
- General Anaesthesia vs Spinal Anaesthesia: Patient Outcomes and Success in Outpatient Primary Total Knee and Hip Arthroplasty (PHASE4)
- Perioperative Effects of Lateral Quadratus Lumborum Block in Percutaneous Transhepatic Cholangiography (NA)
- Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Propofol-remifentanil sedation CI brief — competitive landscape report
- Propofol-remifentanil sedation updates RSS · CI watch RSS
- Erasme University Hospital portfolio CI